Abstract
Cancer is one of the main problems in public health worldwide. Despite rapid advances in the diagnosis and treatment of cancer, the efficacy of current treatment strategies is still limited. There are promising new results in animal models whereby mesenchymal stem cells (MSCs) can be used as vehicles for targeted therapies. The use of MSCs as therapeutic biological vehicles in cell therapy has several advantages, including immune-silence, tumor tropism, easy and rapid isolation, ex vivo expansion, multilineage differentiation and the capacity to deliver a number of therapeutic agents. Some studies have shown that the microenvironment of the tumor provides a preferential niche for homing and survival of MSCs. Here, we have highlighted various applications of MSCs in cancer gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mirzaei H, Sahebkar A, Avan A, Jaafari M, Salehi R, Salehi H et al. Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents. Curr Med Chem 2015; 23: 455–463.
Loebinger MR, Janes SM . Stem cells as vectors for antitumour therapy. Thorax 2010; 65: 362–369.
Bao Q, Zhao Y, Niess H, Conrad C, Schwarz B, Jauch K-W et al. Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev 2012; 21: 2355–2363.
Dwyer RM, Khan S, Barry FP, O’Brien T, Kerin MJ . Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res Ther 2010; 1: 25.
Kolluri KK, Laurent GJ, Janes SM . Mesenchymal stem cells as vectors for lung cancer therapy. Respiration 2013; 85: 443–451.
Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD et al. Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model. Gene Ther 2008; 15: 1446–1453.
Choi SH, Tamura K, Khajuria RK, Bhere D, Nesterenko I, Lawler J et al. Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas. Mol Ther 2015; 23: 235–243.
Stuckey DW, Hingtgen SD, Karakas N, Rich BE, Shah K . Engineering toxin‐resistant therapeutic stem cells to treat brain tumors. Stem Cells 2015; 33: 589–600.
Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155–1164.
Duan X, Guan H, Cao Y, Kleinerman ES . Murine bone marrow–derived mesenchymal stem cells as vehicles for interleukin‐12 gene delivery into Ewing sarcoma tumors. Cancer 2009; 115: 13–22.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mohammadi, M., Jaafari, M., Mirzaei, H. et al. Mesenchymal stem cell: a new horizon in cancer gene therapy. Cancer Gene Ther 23, 285–286 (2016). https://doi.org/10.1038/cgt.2016.35
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2016.35
This article is cited by
-
IL-1β mediated nanoscale surface clustering of integrin α5β1 regulates the adhesion of mesenchymal stem cells
Scientific Reports (2021)
-
Mesenchymal stem cells: ideal seeds for treating diseases
Human Cell (2021)
-
TGF-β1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6
Cell and Tissue Research (2021)
-
Anticancer Effect of Enterocin A-Colicin E1 Fusion Peptide on the Gastric Cancer Cell
Probiotics and Antimicrobial Proteins (2021)
-
Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
Cell Communication and Signaling (2020)